Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cissus Plus is a dietary supplement and nutraceutical primarily composed of *Cissus quadrangularis* extract, a perennial plant of the grape family traditionally used in Ayurvedic medicine. It is widely utilized in the sports nutrition industry for its purported benefits in promoting bone health, accelerating fracture healing, and supporting joint integrity. The primary active constituents are believed to be ketosteroids, which may exhibit glucocorticoid antagonistic properties, thereby potentially reducing the catabolic effects of cortisol on bone and muscle tissue. Additionally, it is thought to stimulate signaling pathways involved in osteoblast differentiation and collagen synthesis. While often marketed for weight loss and metabolic support, its most recognized application is in the management of joint pain and connective tissue recovery. Some formulations under this name may also include synergistic ingredients such as Vitamin C, calcium, or green tea extract.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Cissus Plus.